For decades, immunology textbooks have described a two-step assassination: immune cells use a protein called perforin to punch holes in a target cell’s membrane, then inject enzymes called granzymes through those holes to finish the job. New research from the University of Michigan shows the first step may be far deadlier than anyone assumed — perforin can kill tumour cells entirely on its own.
Rewriting a Textbook Mechanism
Perforin is made by T cells and natural killer (NK) cells, the immune system’s dedicated hunters. The Rogel Cancer Center team found that tumour cells could still be killed even when the major granzymes were missing, upending the assumption that perforin’s holes are merely doorways for other weapons.
The finding matters because cancer immunology advances by understanding precisely which mechanisms do the killing. If perforin is itself a lethal weapon, then tumours that resist granzyme-driven death — a known escape route — might remain vulnerable to perforin delivered in sufficient quantity. The study is among the notable items in the University of Michigan’s recent research and expert releases.
Implications for Cell Therapies
Engineered cell therapies, such as CAR-T treatments, ultimately kill cancer through the same machinery natural immune cells use. Knowing which parts of that machinery are indispensable — and which are redundant — helps engineers design cells that are more potent and more predictable.
It also reframes failures. A therapy that underperforms might not lack target recognition; it might lack enough functional perforin at the point of contact. Measuring and enhancing perforin delivery could become a design goal in its own right, complementing combination approaches such as those explored in an early trial of a personalised vaccine for ovarian cancer.
Perforin: From Mechanism to Medicine, Eventually
As with all mechanism research, the distance from this discovery to a new drug is measured in years. Perforin is dangerous by design — it is how immune cells kill infected and malignant cells, but misdirected perforin damages healthy tissue, and the body regulates it tightly for good reason. Any therapeutic exploitation would need exquisite targeting.
Even so, basic findings of this kind are the compost from which therapies grow. Immunotherapy itself began as curiosity about how immune cells kill; understanding that killer more precisely is rarely wasted effort.
The immune system’s most famous hole-punch turns out to be a weapon in its own right, not just a delivery service for other weapons. It is a small correction to a textbook diagram with potentially large consequences — the kind of finding that quietly redirects a field.
